Recall Z-1702-2019— Angiodynamics Inc. (Navilyst Medical Inc.)
Class II · Terminated
Class II FDA medical device recall by Angiodynamics Inc. (Navilyst Medical Inc.), initiated 2019-04-17, terminated 2020-06-09. It names one FDA 510(k) clearance: K162449. Product: AngioDynamics Solero Microwave Tissue Ablation (MTA) System: (1) Solero Applicator 14cm PG Catalog Number: 700106001 UPN:H7877001060010; (2)Solero Applicator 14cm PG US Catalog Number:700106001US UPN: H787700106001US0 Product Usage: The Solero Microwave Tissue Ablation (MTA) System and accessories are indicated for the ablation of soft tissue during open procedures. The Solero MTA System is not intended for cardiac use.. Reason: Updated Warning Statements in the Operator's Manual/Directions for Use and Software Updates to reduce the risk of potential patient harm due to a delay in performing a procedure.
- Recalling firm
- Angiodynamics Inc. (Navilyst Medical Inc.)
- Classification
- Class II
- Status
- Terminated
- Initiated
- 2019-04-17
- Terminated
- 2020-06-09
- Firm location
- Glens Falls, NY, United States
510(k) clearances named in this recall
1 on FDA's recordK-numbers as listed on FDA's Recall Enterprise System record for this event (openFDA device/recall k_numbers). The recall may also cover devices cleared under other submissions not named here.
Product description
AngioDynamics Solero Microwave Tissue Ablation (MTA) System: (1) Solero Applicator 14cm PG Catalog Number: 700106001 UPN:H7877001060010; (2)Solero Applicator 14cm PG US Catalog Number:700106001US UPN: H787700106001US0 Product Usage: The Solero Microwave Tissue Ablation (MTA) System and accessories are indicated for the ablation of soft tissue during open procedures. The Solero MTA System is not intended for cardiac use.
Reason for recall
Updated Warning Statements in the Operator's Manual/Directions for Use and Software Updates to reduce the risk of potential patient harm due to a delay in performing a procedure
Data sourced from openFDA. This site is unofficial and independent of the FDA.